Physician profile
Paul D Kellam
NPI 1760554877
$1,128.85
in general payments reported to CMS, 2019-2025
17 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.74 · 2020: $53.96 · 2021: $137 · 2022: $112 · 2023: $260 · 2024: $247 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.95 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $181.71 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $175.15 | 2022-2024 | Libtayo, Dupixent |
| Aerin Medical INC. | $147.22 | 2022-2024 | |
| Genzyme Corporation | $130.37 | 2023-2025 | |
| Stryker Corporation | $104.24 | 2022-2023 | Audion Et Dilation System, Xpress Ent Dilation System, Xerogel Nasal/Epistaxis 2 Pack |
| Glaxosmithkline, LLC. | $79.28 | 2025 | Nucala |
| Hikma Pharmaceuticals USA | $68.64 | 2023-2024 | Ryaltris |
| Integra Lifesciences Corporation | $38.45 | 2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Amgen INC. | $34.00 | 2025 | |
| Alk-Abello, INC | $27.72 | 2020 | |
| Inspire Medical Systems, INC. | $25.76 | 2025 | Inspire |
| Medtronic, INC. | $23.56 | 2023 | Pteye Parathyroid Detection System |
| Aroa Biosurgery Incorporated | $20.04 | 2025 | |
| Davol INC. | $19.68 | 2024 | Arista Ah Flexitip |
| Ambu INC. | $18.44 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $17.41 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.18 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kellam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.